| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Frozen Sections | 5 | 2013 | 50 | 1.150 |
Why?
|
| Carcinoma, Renal Cell | 6 | 2017 | 366 | 1.140 |
Why?
|
| Kidney Neoplasms | 9 | 2017 | 557 | 1.080 |
Why?
|
| Pathology | 2 | 2025 | 36 | 0.990 |
Why?
|
| Pathology, Clinical | 1 | 2025 | 39 | 0.890 |
Why?
|
| Pathologists | 1 | 2025 | 40 | 0.880 |
Why?
|
| Career Choice | 1 | 2025 | 164 | 0.800 |
Why?
|
| Treponema pallidum | 2 | 2020 | 8 | 0.710 |
Why?
|
| Stapes | 1 | 2021 | 6 | 0.680 |
Why?
|
| Otosclerosis | 1 | 2021 | 4 | 0.680 |
Why?
|
| Biomarkers, Tumor | 12 | 2018 | 1670 | 0.670 |
Why?
|
| Chancre | 1 | 2020 | 2 | 0.660 |
Why?
|
| Syphilis, Cutaneous | 1 | 2020 | 3 | 0.660 |
Why?
|
| Rectum | 2 | 2020 | 151 | 0.660 |
Why?
|
| Mouth Mucosa | 1 | 2020 | 71 | 0.640 |
Why?
|
| Osteoarthritis | 1 | 2021 | 85 | 0.620 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2019 | 7 | 0.590 |
Why?
|
| Male | 85 | 2021 | 45792 | 0.570 |
Why?
|
| Skin | 2 | 2020 | 604 | 0.560 |
Why?
|
| Adult | 56 | 2021 | 28636 | 0.550 |
Why?
|
| Carcinoma | 8 | 2013 | 444 | 0.550 |
Why?
|
| Melanins | 1 | 2017 | 22 | 0.540 |
Why?
|
| Nephrectomy | 5 | 2017 | 297 | 0.540 |
Why?
|
| DNA-Binding Proteins | 2 | 2017 | 1267 | 0.530 |
Why?
|
| Translocation, Genetic | 2 | 2017 | 250 | 0.530 |
Why?
|
| Immunohistochemistry | 15 | 2019 | 1827 | 0.530 |
Why?
|
| Gene Fusion | 1 | 2017 | 40 | 0.530 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 60 | 0.530 |
Why?
|
| Aged | 52 | 2021 | 20927 | 0.530 |
Why?
|
| Middle Aged | 59 | 2021 | 28299 | 0.530 |
Why?
|
| Chromosomes, Human, X | 1 | 2017 | 57 | 0.530 |
Why?
|
| Humans | 125 | 2025 | 95992 | 0.520 |
Why?
|
| Carcinoma, Squamous Cell | 7 | 2013 | 1087 | 0.510 |
Why?
|
| Echinococcosis | 1 | 2017 | 5 | 0.510 |
Why?
|
| Autopsy | 8 | 2017 | 127 | 0.500 |
Why?
|
| Sinusitis | 3 | 2009 | 222 | 0.500 |
Why?
|
| Adenocarcinoma | 14 | 2016 | 1191 | 0.490 |
Why?
|
| Female | 74 | 2021 | 49980 | 0.470 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 824 | 0.460 |
Why?
|
| Transcription Factors | 2 | 2017 | 1729 | 0.460 |
Why?
|
| Mycoses | 2 | 2006 | 47 | 0.450 |
Why?
|
| Respiratory Tract Infections | 2 | 2019 | 117 | 0.440 |
Why?
|
| Rhabdoid Tumor | 2 | 2008 | 21 | 0.430 |
Why?
|
| Blastomycosis | 2 | 2019 | 7 | 0.410 |
Why?
|
| Biopsy | 10 | 2020 | 1210 | 0.410 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2014 | 463 | 0.410 |
Why?
|
| Pathology, Surgical | 2 | 2009 | 13 | 0.400 |
Why?
|
| Prostatic Neoplasms | 11 | 2018 | 1798 | 0.390 |
Why?
|
| Laryngeal Diseases | 3 | 2011 | 20 | 0.380 |
Why?
|
| Unnecessary Procedures | 1 | 2013 | 55 | 0.370 |
Why?
|
| Nocardia Infections | 1 | 2012 | 4 | 0.370 |
Why?
|
| Synovitis | 1 | 2012 | 15 | 0.370 |
Why?
|
| Immunocompetence | 1 | 2012 | 27 | 0.370 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2013 | 57 | 0.370 |
Why?
|
| Pneumonia, Bacterial | 1 | 2012 | 30 | 0.370 |
Why?
|
| Aged, 80 and over | 15 | 2019 | 7224 | 0.370 |
Why?
|
| Cryptorchidism | 1 | 2011 | 12 | 0.360 |
Why?
|
| Anti-Infective Agents | 1 | 2012 | 96 | 0.350 |
Why?
|
| Vocal Cords | 1 | 2011 | 27 | 0.350 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2011 | 19 | 0.340 |
Why?
|
| Testis | 1 | 2011 | 152 | 0.340 |
Why?
|
| Papillomavirus Infections | 1 | 2014 | 301 | 0.340 |
Why?
|
| Parathyroid Glands | 3 | 2021 | 75 | 0.340 |
Why?
|
| Sjogren's Syndrome | 2 | 2009 | 34 | 0.330 |
Why?
|
| Child | 14 | 2021 | 7621 | 0.320 |
Why?
|
| Thyroid Neoplasms | 2 | 2013 | 443 | 0.320 |
Why?
|
| Warts | 1 | 2010 | 12 | 0.310 |
Why?
|
| Agammaglobulinemia | 1 | 2010 | 20 | 0.310 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2015 | 1464 | 0.310 |
Why?
|
| Mitosporic Fungi | 1 | 2009 | 3 | 0.310 |
Why?
|
| Fungemia | 1 | 2009 | 16 | 0.300 |
Why?
|
| Retrospective Studies | 17 | 2021 | 10307 | 0.290 |
Why?
|
| Young Adult | 6 | 2021 | 7034 | 0.290 |
Why?
|
| Lip | 2 | 2009 | 17 | 0.280 |
Why?
|
| Mouth Neoplasms | 1 | 2010 | 202 | 0.270 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2008 | 65 | 0.260 |
Why?
|
| Diagnosis, Differential | 15 | 2021 | 1618 | 0.260 |
Why?
|
| Lung Diseases, Fungal | 1 | 2007 | 18 | 0.260 |
Why?
|
| Prostatectomy | 6 | 2010 | 480 | 0.250 |
Why?
|
| Adolescent | 14 | 2021 | 9878 | 0.250 |
Why?
|
| Salivary Gland Neoplasms | 2 | 2001 | 81 | 0.240 |
Why?
|
| Immunocompromised Host | 3 | 2016 | 147 | 0.240 |
Why?
|
| Lung Neoplasms | 5 | 2014 | 2384 | 0.240 |
Why?
|
| Nasal Cavity | 4 | 2010 | 94 | 0.240 |
Why?
|
| Coccidioidomycosis | 1 | 2005 | 8 | 0.240 |
Why?
|
| Adenoma | 3 | 2021 | 260 | 0.230 |
Why?
|
| Bone Diseases | 1 | 2005 | 53 | 0.230 |
Why?
|
| Choristoma | 2 | 2021 | 63 | 0.230 |
Why?
|
| Ascomycota | 1 | 2004 | 16 | 0.220 |
Why?
|
| Lymph Nodes | 5 | 2018 | 554 | 0.220 |
Why?
|
| Epistaxis | 1 | 2004 | 20 | 0.220 |
Why?
|
| Paranasal Sinuses | 1 | 2004 | 62 | 0.210 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2004 | 9 | 0.210 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2014 | 382 | 0.200 |
Why?
|
| Fatal Outcome | 6 | 2012 | 303 | 0.200 |
Why?
|
| Nose Neoplasms | 4 | 1997 | 36 | 0.200 |
Why?
|
| Neoplasm Grading | 4 | 2018 | 404 | 0.190 |
Why?
|
| Lymphatic Metastasis | 6 | 2018 | 506 | 0.190 |
Why?
|
| Neoplasm Invasiveness | 5 | 2014 | 579 | 0.190 |
Why?
|
| Lung Abscess | 1 | 2002 | 5 | 0.190 |
Why?
|
| Chromosome Aberrations | 1 | 2004 | 353 | 0.190 |
Why?
|
| Syphilis, Congenital | 1 | 2002 | 9 | 0.180 |
Why?
|
| Keratins | 5 | 2017 | 63 | 0.180 |
Why?
|
| Parathyroid Neoplasms | 2 | 2021 | 60 | 0.180 |
Why?
|
| Insulin-Secreting Cells | 2 | 2017 | 442 | 0.180 |
Why?
|
| Pain | 1 | 2004 | 426 | 0.180 |
Why?
|
| Uterine Neoplasms | 3 | 1996 | 277 | 0.170 |
Why?
|
| Skin Neoplasms | 3 | 1998 | 621 | 0.170 |
Why?
|
| Neck | 3 | 2021 | 99 | 0.170 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2002 | 127 | 0.170 |
Why?
|
| Robotics | 3 | 2008 | 273 | 0.160 |
Why?
|
| Alopecia | 1 | 2020 | 35 | 0.160 |
Why?
|
| Neoplasm Metastasis | 4 | 2014 | 1079 | 0.160 |
Why?
|
| Microscopy, Electron | 13 | 1999 | 488 | 0.160 |
Why?
|
| Soft Tissue Neoplasms | 4 | 2005 | 125 | 0.160 |
Why?
|
| Infant, Premature | 1 | 2002 | 308 | 0.160 |
Why?
|
| Tuberculosis, Laryngeal | 1 | 2019 | 1 | 0.160 |
Why?
|
| Child, Preschool | 8 | 2017 | 3969 | 0.150 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2019 | 26 | 0.150 |
Why?
|
| Laryngoscopy | 1 | 2019 | 50 | 0.150 |
Why?
|
| Neoplasm Staging | 5 | 2018 | 2042 | 0.150 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2013 | 156 | 0.150 |
Why?
|
| Laryngeal Neoplasms | 1 | 2019 | 89 | 0.150 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 1819 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 2 | 2019 | 930 | 0.140 |
Why?
|
| Chicago | 2 | 2017 | 1505 | 0.140 |
Why?
|
| Illinois | 1 | 2020 | 530 | 0.140 |
Why?
|
| Spinal Cord Neoplasms | 1 | 1999 | 80 | 0.140 |
Why?
|
| Phyllodes Tumor | 1 | 2018 | 8 | 0.140 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 241 | 0.140 |
Why?
|
| Polycystic Kidney Diseases | 3 | 1985 | 22 | 0.140 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1998 | 68 | 0.140 |
Why?
|
| GATA3 Transcription Factor | 2 | 2018 | 52 | 0.140 |
Why?
|
| PAX8 Transcription Factor | 1 | 2017 | 24 | 0.140 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 1998 | 17 | 0.140 |
Why?
|
| Ki-67 Antigen | 1 | 1998 | 67 | 0.140 |
Why?
|
| Urinary Bladder | 2 | 2014 | 263 | 0.130 |
Why?
|
| Ploidies | 1 | 1997 | 41 | 0.130 |
Why?
|
| Cystadenocarcinoma, Papillary | 1 | 1996 | 9 | 0.120 |
Why?
|
| Sulfonylurea Compounds | 1 | 2017 | 69 | 0.120 |
Why?
|
| Monosomy | 1 | 2016 | 12 | 0.120 |
Why?
|
| Seminal Vesicles | 1 | 2016 | 39 | 0.120 |
Why?
|
| Infant | 9 | 2017 | 3359 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2006 | 465 | 0.120 |
Why?
|
| DNA, Neoplasm | 1 | 1997 | 272 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2016 | 83 | 0.120 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2017 | 124 | 0.120 |
Why?
|
| Anatomy | 1 | 1996 | 21 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 380 | 0.120 |
Why?
|
| Tissue Array Analysis | 2 | 2013 | 132 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 8 | 2007 | 297 | 0.120 |
Why?
|
| Cadaver | 1 | 1996 | 204 | 0.120 |
Why?
|
| Actinomyces | 1 | 2015 | 5 | 0.110 |
Why?
|
| Earache | 1 | 2015 | 4 | 0.110 |
Why?
|
| Bone Neoplasms | 4 | 1984 | 316 | 0.110 |
Why?
|
| Actinomycosis | 1 | 2015 | 13 | 0.110 |
Why?
|
| Maxillary Sinusitis | 1 | 2015 | 14 | 0.110 |
Why?
|
| Blotting, Western | 1 | 2017 | 796 | 0.110 |
Why?
|
| Cytomegalovirus Infections | 1 | 2016 | 155 | 0.110 |
Why?
|
| Neisseria meningitidis, Serogroup Y | 1 | 2014 | 2 | 0.110 |
Why?
|
| Phenotype | 3 | 2017 | 2575 | 0.110 |
Why?
|
| Prostate | 2 | 2009 | 423 | 0.110 |
Why?
|
| Bile Duct Diseases | 1 | 2014 | 23 | 0.110 |
Why?
|
| Arthritis, Infectious | 1 | 2014 | 18 | 0.110 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2014 | 68 | 0.110 |
Why?
|
| Mutation | 2 | 2017 | 4374 | 0.110 |
Why?
|
| Breast Neoplasms | 5 | 1994 | 3155 | 0.110 |
Why?
|
| Recurrence | 2 | 2014 | 1231 | 0.110 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2014 | 54 | 0.110 |
Why?
|
| Lymphangioma, Cystic | 1 | 1994 | 1 | 0.110 |
Why?
|
| Paranasal Sinus Neoplasms | 3 | 1990 | 26 | 0.110 |
Why?
|
| Kidney | 5 | 2004 | 1135 | 0.100 |
Why?
|
| Epithelial Cells | 1 | 2018 | 704 | 0.100 |
Why?
|
| Education, Medical, Continuing | 1 | 2015 | 112 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 911 | 0.100 |
Why?
|
| Cholangiocarcinoma | 1 | 2014 | 80 | 0.100 |
Why?
|
| Laparoscopy | 4 | 2008 | 784 | 0.100 |
Why?
|
| Carcinoma, Verrucous | 1 | 2013 | 7 | 0.100 |
Why?
|
| Head and Neck Neoplasms | 2 | 2018 | 1087 | 0.100 |
Why?
|
| Uterus | 1 | 1995 | 228 | 0.100 |
Why?
|
| Knee Joint | 1 | 2014 | 166 | 0.100 |
Why?
|
| Lymph Node Excision | 2 | 2016 | 234 | 0.100 |
Why?
|
| Antigens, CD34 | 1 | 2013 | 163 | 0.100 |
Why?
|
| Neoplasms, Multiple Primary | 3 | 2009 | 101 | 0.100 |
Why?
|
| Herpes Simplex | 2 | 1985 | 203 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2006 | 2605 | 0.100 |
Why?
|
| Education, Medical | 1 | 1996 | 252 | 0.100 |
Why?
|
| Adenoviridae Infections | 1 | 2012 | 16 | 0.100 |
Why?
|
| Mesothelioma | 3 | 1983 | 333 | 0.090 |
Why?
|
| Prognosis | 7 | 2018 | 3993 | 0.090 |
Why?
|
| Preoperative Period | 1 | 2013 | 98 | 0.090 |
Why?
|
| Consultants | 1 | 1992 | 7 | 0.090 |
Why?
|
| Endometrial Neoplasms | 1 | 1995 | 228 | 0.090 |
Why?
|
| Follow-Up Studies | 7 | 2007 | 3922 | 0.090 |
Why?
|
| Infant, Newborn | 6 | 2004 | 2611 | 0.090 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2013 | 108 | 0.090 |
Why?
|
| Kidney Diseases, Cystic | 2 | 2004 | 22 | 0.090 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2012 | 18 | 0.090 |
Why?
|
| Microvessels | 1 | 2012 | 69 | 0.090 |
Why?
|
| Precancerous Conditions | 1 | 2013 | 206 | 0.090 |
Why?
|
| Adenolymphoma | 1 | 1992 | 3 | 0.090 |
Why?
|
| Survival Rate | 3 | 2009 | 1978 | 0.090 |
Why?
|
| Head | 1 | 1992 | 131 | 0.090 |
Why?
|
| Seminiferous Tubules | 1 | 2011 | 9 | 0.090 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 2 | 2009 | 19 | 0.090 |
Why?
|
| Thyroidectomy | 1 | 2013 | 173 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2010 | 107 | 0.090 |
Why?
|
| Gestational Age | 2 | 2004 | 343 | 0.090 |
Why?
|
| Insulin | 1 | 2017 | 1191 | 0.090 |
Why?
|
| Breast | 2 | 1992 | 297 | 0.090 |
Why?
|
| Carcinoma, Papillary | 1 | 2013 | 161 | 0.090 |
Why?
|
| Nasopharyngeal Neoplasms | 2 | 1985 | 47 | 0.090 |
Why?
|
| Germ Cells | 1 | 2011 | 134 | 0.080 |
Why?
|
| Neurilemmoma | 2 | 1981 | 40 | 0.080 |
Why?
|
| Actins | 1 | 2013 | 472 | 0.080 |
Why?
|
| Carcinoid Tumor | 2 | 1981 | 45 | 0.080 |
Why?
|
| Vas Deferens | 2 | 1981 | 8 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 354 | 0.080 |
Why?
|
| Olfactory Mucosa | 1 | 2010 | 33 | 0.080 |
Why?
|
| Ovarian Neoplasms | 1 | 1997 | 800 | 0.080 |
Why?
|
| Neuroblastoma | 2 | 1986 | 401 | 0.080 |
Why?
|
| Diabetes Mellitus | 1 | 2017 | 771 | 0.080 |
Why?
|
| Salivary Glands, Minor | 1 | 2009 | 9 | 0.080 |
Why?
|
| Condylomata Acuminata | 1 | 1989 | 15 | 0.080 |
Why?
|
| Collagen | 3 | 1988 | 306 | 0.080 |
Why?
|
| Hyphae | 1 | 2009 | 7 | 0.080 |
Why?
|
| Karyotyping | 2 | 2004 | 224 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2015 | 594 | 0.080 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2010 | 179 | 0.080 |
Why?
|
| Siblings | 1 | 2010 | 109 | 0.080 |
Why?
|
| Bile Duct Neoplasms | 2 | 2014 | 91 | 0.070 |
Why?
|
| Anus Neoplasms | 1 | 1989 | 38 | 0.070 |
Why?
|
| Meningioma | 1 | 1990 | 68 | 0.070 |
Why?
|
| Debridement | 1 | 2009 | 60 | 0.070 |
Why?
|
| Rhabdomyosarcoma | 2 | 1986 | 43 | 0.070 |
Why?
|
| Retroperitoneal Neoplasms | 2 | 1981 | 42 | 0.070 |
Why?
|
| Syndrome | 1 | 2010 | 450 | 0.070 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2000 | 116 | 0.070 |
Why?
|
| Education, Medical, Graduate | 1 | 1993 | 438 | 0.070 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 269 | 0.070 |
Why?
|
| Hemangiosarcoma | 1 | 1988 | 17 | 0.070 |
Why?
|
| DNA, Viral | 1 | 1989 | 272 | 0.070 |
Why?
|
| Papillomaviridae | 1 | 1989 | 180 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 2474 | 0.070 |
Why?
|
| SMARCB1 Protein | 1 | 2008 | 14 | 0.070 |
Why?
|
| Bacterial Infections | 1 | 2010 | 183 | 0.070 |
Why?
|
| Lip Neoplasms | 1 | 1988 | 7 | 0.070 |
Why?
|
| Cytoplasmic Granules | 4 | 1981 | 95 | 0.070 |
Why?
|
| Sural Nerve | 1 | 2007 | 18 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2012 | 700 | 0.070 |
Why?
|
| Intestinal Neoplasms | 1 | 1988 | 70 | 0.070 |
Why?
|
| Artifacts | 1 | 2009 | 254 | 0.070 |
Why?
|
| Nomograms | 1 | 2007 | 35 | 0.070 |
Why?
|
| Decidua | 1 | 1987 | 22 | 0.070 |
Why?
|
| Pneumonia, Viral | 1 | 2012 | 346 | 0.070 |
Why?
|
| Myoepithelioma | 1 | 2007 | 10 | 0.070 |
Why?
|
| Histiocytoma, Benign Fibrous | 2 | 1977 | 23 | 0.070 |
Why?
|
| Metaplasia | 3 | 2018 | 39 | 0.060 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2007 | 9 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2007 | 98 | 0.060 |
Why?
|
| Olfactory Nerve | 1 | 1986 | 2 | 0.060 |
Why?
|
| Erectile Dysfunction | 1 | 2007 | 79 | 0.060 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 1986 | 13 | 0.060 |
Why?
|
| Colonic Neoplasms | 2 | 1988 | 587 | 0.060 |
Why?
|
| Fingers | 1 | 2007 | 69 | 0.060 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 1986 | 8 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2010 | 547 | 0.060 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2007 | 56 | 0.060 |
Why?
|
| Blood Vessels | 1 | 1986 | 91 | 0.060 |
Why?
|
| Antifungal Agents | 1 | 2007 | 126 | 0.060 |
Why?
|
| Peripheral Nervous System Neoplasms | 2 | 1983 | 16 | 0.060 |
Why?
|
| Carcinoma in Situ | 3 | 1997 | 53 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 3 | 2007 | 138 | 0.060 |
Why?
|
| Angiography | 1 | 1986 | 209 | 0.060 |
Why?
|
| Coccidioides | 1 | 2005 | 6 | 0.060 |
Why?
|
| Lymphadenitis | 1 | 1985 | 7 | 0.060 |
Why?
|
| Prostate-Specific Antigen | 3 | 2018 | 346 | 0.060 |
Why?
|
| Pneumonia | 1 | 2007 | 196 | 0.060 |
Why?
|
| Stomach Neoplasms | 1 | 1988 | 310 | 0.060 |
Why?
|
| Liposarcoma | 1 | 2005 | 10 | 0.060 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2005 | 22 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2007 | 740 | 0.050 |
Why?
|
| Vasectomy | 2 | 1981 | 4 | 0.050 |
Why?
|
| Urinary Tract | 1 | 1985 | 33 | 0.050 |
Why?
|
| Liver Diseases | 2 | 2014 | 249 | 0.050 |
Why?
|
| Histocytochemistry | 4 | 2012 | 130 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 1987 | 355 | 0.050 |
Why?
|
| Hepatic Duct, Common | 1 | 1984 | 10 | 0.050 |
Why?
|
| Fetal Heart | 1 | 2004 | 14 | 0.050 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2004 | 14 | 0.050 |
Why?
|
| Tricuspid Valve Stenosis | 1 | 1983 | 4 | 0.050 |
Why?
|
| Incidental Findings | 1 | 2004 | 99 | 0.050 |
Why?
|
| Carcinoma, Small Cell | 2 | 1983 | 117 | 0.050 |
Why?
|
| Lymphoma, B-Cell | 1 | 2004 | 111 | 0.050 |
Why?
|
| Mucins | 2 | 2001 | 40 | 0.050 |
Why?
|
| Sacrococcygeal Region | 1 | 1983 | 13 | 0.050 |
Why?
|
| Cauda Equina | 1 | 1983 | 13 | 0.050 |
Why?
|
| Microscopy | 2 | 2014 | 90 | 0.050 |
Why?
|
| Paraganglioma | 1 | 1983 | 16 | 0.050 |
Why?
|
| Heart Neoplasms | 1 | 1983 | 65 | 0.050 |
Why?
|
| Colon | 1 | 1986 | 540 | 0.050 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 2 | 1986 | 6 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2006 | 983 | 0.050 |
Why?
|
| Teratoma | 1 | 1983 | 58 | 0.050 |
Why?
|
| Fetus | 1 | 2004 | 239 | 0.050 |
Why?
|
| Encephalitis | 1 | 1983 | 101 | 0.050 |
Why?
|
| Lung | 2 | 2012 | 1380 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2004 | 240 | 0.050 |
Why?
|
| Lymphoma | 1 | 1984 | 253 | 0.050 |
Why?
|
| Pleural Neoplasms | 1 | 1983 | 204 | 0.040 |
Why?
|
| Submandibular Gland Neoplasms | 1 | 2001 | 7 | 0.040 |
Why?
|
| Parotid Neoplasms | 1 | 2001 | 16 | 0.040 |
Why?
|
| Adenofibroma | 1 | 1981 | 5 | 0.040 |
Why?
|
| Internship and Residency | 2 | 2009 | 1134 | 0.040 |
Why?
|
| Periosteum | 1 | 1981 | 9 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 1983 | 357 | 0.040 |
Why?
|
| Epithelioid Cells | 1 | 1981 | 13 | 0.040 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 1981 | 12 | 0.040 |
Why?
|
| Mediastinum | 1 | 2021 | 45 | 0.040 |
Why?
|
| Ganglioneuroma | 1 | 1980 | 9 | 0.040 |
Why?
|
| Tibia | 1 | 1981 | 80 | 0.040 |
Why?
|
| Sense Organs | 1 | 1980 | 7 | 0.040 |
Why?
|
| Disease-Free Survival | 3 | 2018 | 1195 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2006 | 517 | 0.040 |
Why?
|
| Cheek | 1 | 1980 | 21 | 0.040 |
Why?
|
| Carcinoembryonic Antigen | 3 | 1986 | 41 | 0.040 |
Why?
|
| Mouth | 1 | 1980 | 49 | 0.040 |
Why?
|
| Mycobacterium fortuitum | 1 | 2019 | 1 | 0.040 |
Why?
|
| Hoarseness | 1 | 2019 | 11 | 0.040 |
Why?
|
| Blastomyces | 1 | 2019 | 3 | 0.040 |
Why?
|
| Brachial Plexus | 1 | 1999 | 5 | 0.040 |
Why?
|
| Culture Techniques | 1 | 2019 | 87 | 0.040 |
Why?
|
| Serotonin | 1 | 1980 | 219 | 0.040 |
Why?
|
| Rectal Neoplasms | 1 | 1980 | 134 | 0.040 |
Why?
|
| Hyperplasia | 2 | 2013 | 149 | 0.040 |
Why?
|
| Cough | 1 | 2019 | 57 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 2042 | 0.040 |
Why?
|
| Staining and Labeling | 3 | 1987 | 163 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2009 | 4690 | 0.040 |
Why?
|
| Hemangioma | 1 | 1979 | 65 | 0.040 |
Why?
|
| Pregnancy | 2 | 2002 | 3239 | 0.040 |
Why?
|
| Brain Neoplasms | 2 | 1981 | 848 | 0.040 |
Why?
|
| Necrosis | 2 | 1992 | 212 | 0.040 |
Why?
|
| Liver Circulation | 1 | 1978 | 30 | 0.040 |
Why?
|
| Cysts | 2 | 1992 | 104 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2017 | 1962 | 0.030 |
Why?
|
| Kallikreins | 1 | 2018 | 46 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 3 | 1986 | 43 | 0.030 |
Why?
|
| Calcitonin | 2 | 1989 | 40 | 0.030 |
Why?
|
| Schwann Cells | 3 | 1986 | 34 | 0.030 |
Why?
|
| Matched-Pair Analysis | 1 | 1997 | 40 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2004 | 747 | 0.030 |
Why?
|
| Leiomyoma | 1 | 1981 | 211 | 0.030 |
Why?
|
| Animals | 2 | 2014 | 28901 | 0.030 |
Why?
|
| Pancreas | 2 | 2015 | 263 | 0.030 |
Why?
|
| Wolffian Ducts | 1 | 1976 | 8 | 0.030 |
Why?
|
| Adnexa Uteri | 1 | 1976 | 11 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2017 | 235 | 0.030 |
Why?
|
| Terminology as Topic | 2 | 2014 | 227 | 0.030 |
Why?
|
| Dissection | 1 | 1996 | 45 | 0.030 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 1995 | 7 | 0.030 |
Why?
|
| Survivors | 1 | 1997 | 204 | 0.030 |
Why?
|
| Kidney Glomerulus | 1 | 1976 | 122 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 1998 | 340 | 0.030 |
Why?
|
| Maxillary Sinus | 1 | 2015 | 21 | 0.030 |
Why?
|
| Ethmoid Sinus | 2 | 1986 | 7 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 1997 | 725 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 364 | 0.030 |
Why?
|
| Pancreatic Function Tests | 1 | 2015 | 7 | 0.030 |
Why?
|
| Somatostatin-Secreting Cells | 1 | 2015 | 7 | 0.030 |
Why?
|
| Lithiasis | 1 | 2014 | 2 | 0.030 |
Why?
|
| Carboplatin | 1 | 1996 | 328 | 0.030 |
Why?
|
| Neoplasms, Second Primary | 1 | 1997 | 245 | 0.030 |
Why?
|
| Cholangiography | 1 | 2014 | 38 | 0.030 |
Why?
|
| Cholelithiasis | 1 | 2014 | 36 | 0.030 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2015 | 27 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 2014 | 56 | 0.030 |
Why?
|
| Microbiological Techniques | 1 | 2014 | 25 | 0.030 |
Why?
|
| Silver | 2 | 1987 | 17 | 0.030 |
Why?
|
| Medical Staff, Hospital | 1 | 1975 | 110 | 0.030 |
Why?
|
| Laser Capture Microdissection | 1 | 2014 | 20 | 0.030 |
Why?
|
| Cartilage | 1 | 1975 | 116 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 1996 | 270 | 0.030 |
Why?
|
| Causality | 1 | 2014 | 84 | 0.030 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 1975 | 126 | 0.030 |
Why?
|
| Papanicolaou Test | 1 | 1994 | 39 | 0.030 |
Why?
|
| Urogenital Neoplasms | 1 | 1974 | 25 | 0.030 |
Why?
|
| Paclitaxel | 1 | 1996 | 488 | 0.030 |
Why?
|
| Vaginal Smears | 1 | 1994 | 71 | 0.030 |
Why?
|
| Inflammation | 3 | 2010 | 1063 | 0.030 |
Why?
|
| Fetal Death | 1 | 1994 | 57 | 0.030 |
Why?
|
| Age of Onset | 1 | 2015 | 345 | 0.030 |
Why?
|
| Pediatrics | 1 | 1998 | 399 | 0.030 |
Why?
|
| Cell Nucleus | 4 | 1977 | 618 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 1994 | 110 | 0.020 |
Why?
|
| Ethics, Medical | 1 | 1996 | 312 | 0.020 |
Why?
|
| Salaries and Fringe Benefits | 1 | 1993 | 25 | 0.020 |
Why?
|
| Tonsillitis | 1 | 1992 | 5 | 0.020 |
Why?
|
| Faculty | 1 | 1993 | 36 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 548 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2017 | 873 | 0.020 |
Why?
|
| Research Support as Topic | 1 | 1993 | 92 | 0.020 |
Why?
|
| Microcirculation | 1 | 2012 | 104 | 0.020 |
Why?
|
| Brain | 1 | 1983 | 2479 | 0.020 |
Why?
|
| Family Health | 1 | 2012 | 159 | 0.020 |
Why?
|
| Observer Variation | 1 | 2014 | 626 | 0.020 |
Why?
|
| Nasal Polyps | 1 | 1992 | 64 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 1992 | 162 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 1017 | 0.020 |
Why?
|
| Survival Analysis | 1 | 1994 | 1541 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 60 | 0.020 |
Why?
|
| Agnosia | 1 | 2010 | 6 | 0.020 |
Why?
|
| Pregnadienediols | 1 | 2010 | 13 | 0.020 |
Why?
|
| Poaceae | 1 | 2010 | 19 | 0.020 |
Why?
|
| Ambrosia | 1 | 2010 | 14 | 0.020 |
Why?
|
| Mometasone Furoate | 1 | 2010 | 19 | 0.020 |
Why?
|
| Quality of Life | 2 | 2010 | 1816 | 0.020 |
Why?
|
| Inhalation | 1 | 2010 | 34 | 0.020 |
Why?
|
| Pelvis | 1 | 2010 | 103 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 2010 | 140 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 1931 | 0.020 |
Why?
|
| Radiography | 2 | 1983 | 823 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 1976 | 725 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2004 | 2777 | 0.020 |
Why?
|
| Capsid | 1 | 1989 | 25 | 0.020 |
Why?
|
| Hyperparathyroidism | 1 | 1989 | 65 | 0.020 |
Why?
|
| Pollen | 1 | 2010 | 87 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2007 | 9228 | 0.020 |
Why?
|
| Thyroglobulin | 1 | 1989 | 59 | 0.020 |
Why?
|
| Eosinophils | 1 | 2010 | 196 | 0.020 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1990 | 58 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 1989 | 135 | 0.020 |
Why?
|
| Allergens | 1 | 2010 | 191 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1999 | 3642 | 0.020 |
Why?
|
| Glioma | 2 | 1990 | 321 | 0.020 |
Why?
|
| Sarcoma, Kaposi | 1 | 1988 | 18 | 0.020 |
Why?
|
| Parathyroid Hormone | 1 | 1989 | 228 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 348 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2009 | 231 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 4 | 1 | 2007 | 3 | 0.020 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2007 | 10 | 0.020 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2007 | 19 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2885 | 0.020 |
Why?
|
| Jamaica | 1 | 2007 | 5 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2007 | 113 | 0.020 |
Why?
|
| HIV Infections | 1 | 2016 | 974 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 1986 | 26 | 0.020 |
Why?
|
| S100 Proteins | 1 | 1986 | 53 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2006 | 68 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2007 | 600 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2007 | 137 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2007 | 152 | 0.010 |
Why?
|
| Groin | 1 | 1985 | 11 | 0.010 |
Why?
|
| Kidney Cortex | 2 | 1976 | 32 | 0.010 |
Why?
|
| Virion | 1 | 1985 | 62 | 0.010 |
Why?
|
| Deoxycytidine | 1 | 2006 | 216 | 0.010 |
Why?
|
| Organoids | 2 | 1976 | 78 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1996 | 2385 | 0.010 |
Why?
|
| United States | 2 | 2014 | 7785 | 0.010 |
Why?
|
| Neoplasm Seeding | 1 | 2004 | 16 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2007 | 1156 | 0.010 |
Why?
|
| Amyloidosis | 1 | 1986 | 139 | 0.010 |
Why?
|
| Cisplatin | 1 | 2006 | 599 | 0.010 |
Why?
|
| Cholangitis | 1 | 1984 | 19 | 0.010 |
Why?
|
| Sclerosis | 1 | 1984 | 32 | 0.010 |
Why?
|
| Logistic Models | 1 | 2007 | 1273 | 0.010 |
Why?
|
| Microvilli | 1 | 1984 | 44 | 0.010 |
Why?
|
| Mesentery | 1 | 1984 | 47 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2007 | 1642 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2006 | 936 | 0.010 |
Why?
|
| Thorax | 1 | 1983 | 79 | 0.010 |
Why?
|
| Chorionic Gonadotropin | 1 | 1983 | 72 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1984 | 144 | 0.010 |
Why?
|
| alpha-Fetoproteins | 1 | 1983 | 46 | 0.010 |
Why?
|
| Pericardium | 1 | 1983 | 84 | 0.010 |
Why?
|
| Disease Progression | 1 | 2007 | 1561 | 0.010 |
Why?
|
| Sterilization Reversal | 1 | 1981 | 2 | 0.010 |
Why?
|
| Heart Atria | 1 | 1983 | 297 | 0.010 |
Why?
|
| Granuloma | 1 | 1981 | 65 | 0.010 |
Why?
|
| Sutures | 1 | 1981 | 59 | 0.010 |
Why?
|
| Spermatozoa | 1 | 1981 | 69 | 0.010 |
Why?
|
| Palliative Care | 1 | 1983 | 271 | 0.010 |
Why?
|
| Neurofibromatosis 1 | 1 | 1981 | 45 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1981 | 35 | 0.010 |
Why?
|
| Clavicle | 1 | 1981 | 13 | 0.010 |
Why?
|
| Conjunctival Neoplasms | 1 | 1980 | 2 | 0.010 |
Why?
|
| Fluorescence | 1 | 1980 | 103 | 0.010 |
Why?
|
| Sex Factors | 1 | 1984 | 1130 | 0.010 |
Why?
|
| Desmosomes | 1 | 1980 | 11 | 0.010 |
Why?
|
| Astrocytoma | 1 | 1981 | 89 | 0.010 |
Why?
|
| Myocardium | 1 | 1983 | 606 | 0.010 |
Why?
|
| Parotid Gland | 1 | 1980 | 26 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 2534 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 3483 | 0.010 |
Why?
|
| Maternal Age | 1 | 2000 | 48 | 0.010 |
Why?
|
| Microtubules | 1 | 1980 | 134 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2007 | 2498 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1981 | 195 | 0.010 |
Why?
|
| Hemangiopericytoma | 1 | 1979 | 2 | 0.010 |
Why?
|
| Hemangioendothelioma | 1 | 1979 | 9 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1981 | 358 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2007 | 2860 | 0.010 |
Why?
|
| Epithelium | 1 | 1980 | 322 | 0.010 |
Why?
|
| Prenatal Care | 1 | 2000 | 84 | 0.010 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2000 | 77 | 0.010 |
Why?
|
| Genital Diseases, Male | 1 | 1978 | 9 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 1980 | 200 | 0.010 |
Why?
|
| Cause of Death | 1 | 2000 | 279 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1985 | 1425 | 0.010 |
Why?
|
| Oxymetholone | 1 | 1978 | 1 | 0.010 |
Why?
|
| Fluoxymesterone | 1 | 1978 | 2 | 0.010 |
Why?
|
| Splenic Rupture | 1 | 1978 | 7 | 0.010 |
Why?
|
| Iatrogenic Disease | 1 | 1978 | 72 | 0.010 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 1978 | 67 | 0.010 |
Why?
|
| Histiocytes | 1 | 1977 | 22 | 0.010 |
Why?
|
| Glomerulonephritis | 1 | 1978 | 80 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 1978 | 148 | 0.010 |
Why?
|
| Capillaries | 1 | 1977 | 85 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 1978 | 188 | 0.010 |
Why?
|
| Spleen | 1 | 1978 | 419 | 0.010 |
Why?
|
| Risk Factors | 1 | 2007 | 5992 | 0.010 |
Why?
|
| Catecholamines | 1 | 1977 | 92 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2007 | 3581 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2007 | 2603 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1977 | 288 | 0.010 |
Why?
|
| Length of Stay | 1 | 2000 | 835 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 1978 | 369 | 0.010 |
Why?
|
| Gynecomastia | 1 | 1975 | 8 | 0.010 |
Why?
|
| Failure to Thrive | 1 | 1995 | 17 | 0.010 |
Why?
|
| Kidney Tubules | 1 | 1976 | 91 | 0.010 |
Why?
|
| Muscle Hypotonia | 1 | 1995 | 49 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 1977 | 263 | 0.010 |
Why?
|
| Hydronephrosis | 1 | 1975 | 30 | 0.010 |
Why?
|
| Reticulin | 1 | 1974 | 3 | 0.010 |
Why?
|
| Mullerian Ducts | 1 | 1974 | 20 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 1974 | 49 | 0.010 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 1974 | 39 | 0.010 |
Why?
|
| Glycogen | 1 | 1974 | 59 | 0.010 |
Why?
|
| Hyaluronic Acid | 1 | 1974 | 53 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1977 | 776 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 1978 | 353 | 0.010 |
Why?
|
| Liver | 1 | 1978 | 1231 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 12525 | 0.010 |
Why?
|
| Mastectomy | 1 | 1975 | 270 | 0.010 |
Why?
|
| Testicular Neoplasms | 1 | 1974 | 122 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1975 | 323 | 0.010 |
Why?
|
| Combined Modality Therapy | 2 | 1986 | 1741 | 0.010 |
Why?
|
| Neurons | 1 | 1980 | 1654 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 1975 | 432 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1977 | 1662 | 0.000 |
Why?
|
| Nasal Septum | 1 | 1990 | 27 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1976 | 790 | 0.000 |
Why?
|
| Maxillary Sinus Neoplasms | 1 | 1986 | 7 | 0.000 |
Why?
|
| Orbital Neoplasms | 1 | 1986 | 16 | 0.000 |
Why?
|
| Mucin-1 | 1 | 1986 | 46 | 0.000 |
Why?
|
| Bone Marrow Examination | 1 | 1984 | 41 | 0.000 |
Why?
|
| Vincristine | 1 | 1984 | 101 | 0.000 |
Why?
|
| Ankle | 1 | 1984 | 27 | 0.000 |
Why?
|
| Larynx | 1 | 1984 | 35 | 0.000 |
Why?
|
| Phagocytosis | 1 | 1984 | 111 | 0.000 |
Why?
|
| Methotrexate | 1 | 1984 | 232 | 0.000 |
Why?
|
| Prednisone | 1 | 1984 | 252 | 0.000 |
Why?
|
| Cyclophosphamide | 1 | 1984 | 292 | 0.000 |
Why?
|
| Neoplastic Stem Cells | 1 | 1984 | 173 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1984 | 789 | 0.000 |
Why?
|
| Giant Cells | 1 | 1981 | 19 | 0.000 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1981 | 59 | 0.000 |
Why?
|
| Meningeal Neoplasms | 1 | 1981 | 73 | 0.000 |
Why?
|
| Membrane Proteins | 1 | 1986 | 1275 | 0.000 |
Why?
|
| Sarcoma | 1 | 1981 | 224 | 0.000 |
Why?
|